ClinConnect ClinConnect Logo
Search / Trial NCT06378554

Cereset Research for Performance Improvement in a Hospital Nursing Unit

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 17, 2024

Trial Information

Current as of July 05, 2025

Enrolling by invitation

Keywords

Anxiety Stress Insomnia Cereset Research Brain Electrical Activity Neurotechnology Hirrem Neuromodulation Acoustic Stimulation Healthcare Worker

ClinConnect Summary

This is a pre-post design quality improvement project and implementation study, evaluating implementation measures, group level quality measures using QI methodology, and individual-level behavioral and performance measures before and after implementation of the Cereset Research (CR) evidence-based intervention among nursing unit staff. Individual-level behavioral symptoms and a nursing performance metric will be evaluated among healthcare workers in the nursing unit in the pre- and post-implementation timeframes among individuals who consent to participate in these evaluation activities. U...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ability to comply with basic instructions and be able to sit still, comfortably during sessions.
  • Healthcare worker in the Orthopedic Trauma Unit at Atrium Health Wake Forest Baptist, aged 18 years and older.
  • Exclusion Criteria:
  • Unable, unwilling, or incompetent to provide informed consent.
  • Physically unable to come to the study visits.
  • Severe hearing impairment (because CR involves acoustic stimulation that participants would need to be able to hear).
  • Weight is over the chair limit (400 pounds).
  • Currently enrolled in another Cereset Research study.
  • Use of the following modalities within one month before enrollment: electroconvulsive therapy (ECT), prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, eye movement desensitization and reprocessing (EMDR), brain spotting, neurofeedback, biofeedback, or deep brain stimulation (DBS). Individuals will be given the opportunity to discontinue these techniques for one month and then enroll.
  • Known seizure disorder.
  • Thoughts of active suicide within the last 3 months.

About Wake Forest University Health Sciences

Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.

Locations

Winston Salem, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Charles H Tegeler, MD

Principal Investigator

Wake Forest University Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported